why do pbms have different rules for glp-1 coverage CMS Issues Guidance on Anti-Obesity Drugs As more Americans turn to
Description
Tirzepatide, initially approved for diabetes treatment, now also treats weight loss
10.1155/2018/8309723 Int

The other two actions are helpful for weight loss- the food takes longer to digest and the feeling of being hungry is suppressed
The three recommended injection sites for GLP-1s are the stomach/abdomen, thighs, and upper arms

The urgency was compounded by Lillys ascendancy: if Pfizer did not act aggressively, Lilly might also build on these assets or something equivalent

Sources U.S
